Clinical Trial Update: Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial at Stanford is evaluating statin therapy for primary sclerosing cholangitis using a multi-omics approach. The study is currently in the r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Sclerosing Cholangitis

Drugs mentioned

• Statin therapy (statin)

Snippet

Sponsor: Stanford University | Conditions: Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases | EARLY_Phase 1 | Status: RECRUITING